Detalhe da pesquisa
1.
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.
Br J Cancer
; 115(10): 1223-1233, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27685445